BSE · SAMRATPH

Samrat Pharmachem Ltd.

Sector: Chemicals · ISIN: INE103E01016

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,110

of 5,004 stocks

🏆 New peak

▲ 721W

Peak #3,110 · 01 Oct 2026

Samrat Pharmachem Ltd., a microcap Chemicals business, has a subdued return on equity, is growing revenue modestly, and has promoters holding 49%. Ownership as of Jun 2026.

Market Cap

74.68 Cr

P/E Ratio

—

P/B Ratio

1.10

ROE

-4.86%

ROCE

-3.71%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	79.76 Cr	71.77 Cr	63.43 Cr	78.87 Cr
Net Profit	87.60 L	-2.04 Cr	-45.95 L	-58.73 L
EPS	2.84	-6.59	1.49	-1.90
Operating Profit	1.70 Cr	-1.43 Cr	-44.15 L	-54.12 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

49.09%

Public

50.91%

PUBLIC BREAKDOWN

FII

3.24%

Individuals

43.46%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
18 Sep 2025	Dividend	Final Dividend - Rs. - 1.0000
19 Sep 2024	Dividend	Final Dividend - Rs. - 1.0000
18 Sep 2023	Dividend	Dividend - Rs. - 1.0000
22 Sep 2022	Dividend	Dividend - Rs. - 1.0000

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs